The Nigerian government has introduced measures to make cancer treatment more affordable, though costs remain out of reach for many patients, according to officials.
A single statement from a government official gestures at a large problem. Nigeria is expanding funding for cancer care and working to increase local drug production, according to Premium Times — but the gap between policy and patient remains wide.
Mr Aliyu, speaking on behalf of the government, said new measures had been introduced to make cancer care more affordable, Premium Times reported. He acknowledged, however, that treatment costs remain beyond the reach of many Nigerians.
The report did not specify which cancers or treatments the new funding targets, nor did it detail how local drug production would be scaled or by whom.
Why this matters for people with albinism
Skin cancer is the leading cause of death among people with albinism in sub-Saharan Africa, according to the World Health Organisation. In Nigeria, where sunscreen is expensive and specialist dermatology is concentrated in urban centres, access to affordable cancer treatment is not a peripheral concern — it is a survival question.
Any meaningful expansion of cancer funding in Nigeria could, if designed inclusively, reduce the cost burden on people with albinism who develop squamous cell carcinoma — the skin cancer most commonly linked to long-term UV exposure without protection. Whether this policy reaches that population remains unaddressed in the current reporting.
Premium Times did not confirm a timeline for implementation or publish additional detail on the scope of the funding.
Keywords
Core topics and entities mentioned in this summary.